WP
CABA icon

Woodline Partners’s Cabaletta Bio CABA Stock Holding History

Woodline Partners’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Buy
4,200,142
+2,949,900
+236% +$9.7M 0.04% 472
2026
Q1 		$3.36M Hold
1,250,242
– – 0.01% 729
2025
Q4 		$2.74M Sell
1,250,242
-885,106
-41% -$2.19M 0.01% 734
2025
Q3 		$5M Buy
2,135,348
+916,884
+75% +$1.57M 0.02% 568
2025
Q2 		$1.85M Buy
+1,218,464
New +$1.9M 0.01% 733
2024
Q3 		– Sell
-242,981
Closed -$1.82M – 612
2024
Q2 		$1.82M Buy
242,981
+318
+0.1% +$3.9K 0.02% 426
2024
Q1 		$4.14M Buy
242,663
+1,210
+0.5% +$26K 0.04% 379
2023
Q4 		$5.48M Buy
241,453
+107,269
+80% +$1.8M 0.06% 307
2023
Q3 		$2.04M Buy
+134,184
New +$1.83M 0.02% 399

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Woodline Partners's CABA Position: Q2 2026 in Review

Woodline Partners increased its Cabaletta Bio (CABA) stake by 236% in Q2 2026, buying an estimated $9.7M and bringing the position to 4,200,142 shares worth $13.1M. The position accounts for 0.04% of the portfolio, ranked #472.

Woodline Partners first reported a position in CABA in Q3 2023 and has held it in 9 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Woodline Partners held 4,200,142 shares of Cabaletta Bio worth $13.1M as of Q2 2026.
  • Woodline Partners bought 2,949,900 Cabaletta Bio shares in Q2 2026, an estimated $9.7M.
  • Cabaletta Bio made up 0.04% of Woodline Partners's portfolio in Q2 2026, its #472 holding.
  • Woodline Partners first reported a position in Cabaletta Bio in Q3 2023 and has held it in 9 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.